EGFR gene signature predicts non-small cell lung cancer prognosis
Wednesday, January 13, 2010 - 08:07
in Health & Medicine
Epidermal growth factor receptor (EGFR) is a validated therapeutic target for non-small cell lung cancer. Researchers have now discovered a 93-gene signature that is associated with the presence of EGFR mutations in tumours from lung cancer patients and is a favourable prognostic marker in patients with early stage lung cancer...